ANNEXU.K.
In point A of Annex III to Directive 2004/37/EC, the following rows are added:
| a Inhalable fraction. | ||||||||||
| b Inhalable fraction. Respirable fraction in those Member States that implement, on the date of the entry into force of this Directive, a biomonitoring system with a biological limit value not exceeding 0,002 mg Cd/g creatinine in urine. | ||||||||||
| c The substance can cause sensitisation of the skin and of the respiratory tract. | ||||||||||
| d The substance can cause sensitisation of the skin.’. | ||||||||||
| Name of agent | EC No (1) | CAS No (2) | Limit values | Notation | Transitional measures | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 8 hours (3) | Short-term (4) | |||||||||
| mg/m3 (5) | ppm (6) | f/ml (7) | mg/m3 (5) | ppm (6) | f/ml (7) | |||||
| ‘Cadmium and its inorganic compounds | — | — | 0,001a | — | — | — | — | — | Limit value 0,004 mg/m3 b until 11 July 2027 | |
| Beryllium and inorganic beryllium compounds | — | — | 0,0002a | — | — | — | — | — | dermal and respiratory sensitisationc | Limit value 0,0006 mg/m3 until 11 July 2026 |
| Arsenic acid and its salts, as well as inorganic arsenic compounds | — | — | 0,01a | — | — | — | — | — | — | For the copper smelting sector, the limit value shall apply from 11 July 2023 |
| Formaldehyde | 200-001-8 | 50-00-0 | 0,37 | 0,3 | — | 0,74 | 0,6 | — | dermal sensitisationd | Limit value of 0,62 mg/m3 or 0,5 ppm (3) for the health care, funeral and embalming sectors until 11 July 2024 |
| 4,4′-Methylene-bis (2-chloroaniline) | 202-918-9 | 101-14-4 | 0,01 | — | — | — | — | — | skin (10) | |